I am/have/had
I am looking for
Advanced Filters
Found 242 clinical trials
NUVOLA TRIAL Open-label Multicentre Study
Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in BRCA1 or BRCA2 genes. Recent evidences showed that OC women with germline BRCA1/2 mutations (gBRCAmut) have an improved survival and higher platinum-sensitivity compared to BRCA1/2 naive (BRCAwt).
sterilisation
skin cancer
measurable disease
peripheral blood smear
recurrent ovarian cancer
- 0 views
- 19 Feb, 2024